| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q1 | May 9, 2024 | Greenlight Capital | 1.1% | 9.0% | BHF, CEIX, FHN, GRBK, HPQ, IMVT, KD, LBTYA, NYCB, PENN, ROIV, SOLB.BR, TECK, THC, VTSC.DE | AI, Copper, Long/Short, Macro, market structure, Passive investing, undervaluation, value | Greenlight established a position in HP Inc. to benefit from a potential AI-driven PC adoption cycle. Intel plans to release neural processing units this summer, and Microsoft is teasing AI features requiring NPUs. The firm believes AI optimism is not reflected in HPQ's share price. | LBTYA ROIV HPQ PENN SOLB.BR |
View |
| 2024 Q1 | Apr 15, 2024 | Meridian Contrarian Fund | 6.9% | 0.0% | AXS, BEPC, CACI, CCJ, CRC, FCNCA, NVTS, PRGO, QDEL, SG, SGH, THC, VICI | contrarian, earnings, healthcare, semiconductors, small caps, technology, turnaround, value | Fund holds positions in semiconductor companies including Navitas Semiconductor Corp., which designs and produces highly efficient power semiconductors and leads in Gallium Nitride (GaN) technology. The company overcame significant technological hurdles to create competitive advantages in power efficiency and charging speeds over traditional silicon. | THC SG SGH NVTS BEPC QDEL |
View |
| 2024 Q4 | Feb 10, 2025 | Meridian Contrarian Fund | 1.7% | 9.6% | AXS, BEPC, BWXT, CCO, CSTM, FCNCA, HNST, LEGN, LPLA, MIR, PL, PRGO, THC | aerospace, contrarian, healthcare, nuclear, small cap, turnaround, value | The fund employs a contrarian investment process seeking out-of-favor companies with depressed valuations and visible catalysts for sustainable improvement. They screen for companies with multiple quarters of year-over-year earnings decline and identify those poised for earnings rebounds through turnaround plans, new management, or business improvements. | THC CSTM LEGN PL MIR HNST |
View |
| 2023 Q4 | Dec 31, 2023 | Meridian Contrarian Fund | 6.9% | 0.0% | ALEX, AMD, APA, CACI, CCJ, CRC, FCNCA, HNST, LEGN, PINS, PRGO, SGH, TAP, THC, VICI | Biotechnology, contrarian, energy, semiconductors, small caps, turnaround, value | AMD positioned as stronger competitor to Nvidia with compelling technology and superior products to Intel. The company unveiled details about upcoming GPU products for the AI market, with expectations that AMD's GPU servers will be a viable alternative to Nvidia. | PINS HNST AMD ADNT|APA|BPOP|FLR|KOS|OLN LEGN SGH |
View |
| 2023 Q3 | Oct 10, 2023 | Oakmark Global Fund | 7.5% | 0.0% | ALV.DE, AMZN, BC, CHTR, CNHI, COP, CSCO, FLS, GOOGL, IPG, NVST, ORCL, PH, PRU.L, STJ.L, THC | Cloud, global, Networking, software, technology, Telecommunications, value | Oracle's cloud business is showing strong momentum with infrastructure cloud services growing 72% and strategic back office cloud reaching $6.9 billion in run-rate revenue. The company signed several deals greater than $1 billion in total value during the quarter and booked an additional $1.5 billion in the first week of the second quarter. | CSCO ABC ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO STJ.L CHTR |
View |
| 2024 Q3 | Sep 30, 2024 | ClearBridge Investments Mid Cap Growth Strategy | 0.0% | 0.0% | APP, APTV, AVTR, CCK, CPAY, DKNG, ETSY, FIVE, FRSH, ICLR, PFGC, PINS, RARE, RRX, SBAC, SUI, THC, VST, VYX, WK | healthcare, industrials, interest rates, mid cap, Quality, technology, Value rotation | AppLovin represents one of the best examples of an AI beneficiary in the mid cap market, having already incorporated AI capabilities into its platform. This translates into more effective take rates on clients' mobile games and transactions, with mobile games representing only the tip of the iceberg of AppLovin's potential for its AI-enabled platform. | View | |
| 2024 Q3 | Sep 30, 2024 | Meridian Contrarian Fund | 6.9% | 0.0% | AXS, BEPC, BOWL, BWXT, CACI, CARS, CCJ, EVRG, FCNCA, NVTS, PRGO, PRT, THC, VICI | contrarian, defense, healthcare, small caps, technology, turnaround, value | The fund holds Navitas Semiconductor, a leader in Gallium Nitride technology for power semiconductors. Despite cyclical headwinds in mobile, EV, and solar markets causing revenue guidance to come in lower than expected, the manager increased the position based on confidence in long-term secular outlook for energy-efficient semiconductors and Navitas' technological leadership. | THC CACI KRNT CARS BOWL NVTS |
View |
| 2024 Q2 | Jun 30, 2024 | Meridian Contrarian Fund | 6.9% | 0.0% | AMSC, AXS, BEPC, CACI, CCJ, CRC, CRNC, EYE, FCNCA, PRGO, SGH, THC, VICI | contrarian, healthcare, Renewable Energy, small cap, turnaround, value | Fund employs a contrarian value strategy seeking out-of-favor companies with depressed valuations and visible catalysts for sustainable improvement. The process screens for companies with multiple quarters of earnings declines and identifies those poised for earnings rebounds through turnaround plans or management changes. | BEPC AMSC THC PRGO CRNC EYE |
View |
| 2024 Q2 | Jun 30, 2024 | Franklin High Income Fund | 1.7% | 0.0% | CCL, THC, VST | Corporate Bonds, credit, fixed income, high yield | View | ||
| 2023 Q2 | Jun 30, 2023 | Oakmark Global Fund | 7.5% | 0.0% | AIG, AMZN, ARNC, BABA, BAC, BUD, CNHI, COP, CRBG, CWK, DHR, GLEN.L, GOOGL, IQV, MBG.DE, NOV, ORCL, RYAAY, THC | energy, global, insurance, Life Sciences, technology, value | The fund initiated positions in Danaher and IQVIA Holdings, both leaders in life sciences. Danaher maintains a portfolio focused on bioprocessing, life science tools, genomics and diagnostics with secular growth opportunities. IQVIA is positioned at the heart of trends toward advanced therapeutics and personalized medicine as the most levered CRO to decentralized clinical trials. | IQV DHR CRBG |
View |
| 2023 Q4 | Apr 30, 2024 | Crossroads Capital | 4.2% | 8.9% | AAPL, AMZN, AWE.L, CLMT, GOOGL, META, MSFT, NTDOY, NVDA, NVR, THC, TSLA, VTY.L, XLK | AI, China, Energy Transition, gaming, Homebuilders, small caps, technology, value | Manager discusses AI as a revolutionary technology driving data center infrastructure investment and creating bottlenecks in networking. Highlights Alphawave Semi's exposure to AI-driven demand with 60% of pipeline tied to AI applications. | View | |
| 2023 Q4 | Jan 22, 2024 | Greenlight Capital | 1.1% | 9.0% | ALIT, ATVI, BHF, CEIX, GRBK, KD, SWN, SYENS.BR, THC, VTRS, VTSC.DE | Buybacks, energy, Geopolitical, healthcare, Long/Short, technology, value | Greenlight emphasizes disciplined valuation criteria and investments where they get paid by issuers through buybacks, dividends, interest, or take-outs rather than relying on investor revaluation. Many of their largest holdings offer double-digit returns directly to investors. | SYENS.BR VTRS ALIT VTSC.DE THC BKD CEIX GRBK |
View |
| 2024 Q4 | Jan 21, 2025 | Greenlight Capital | - | 7.2% | AAPL, BHF, CEIX, CNC, CNH, CPRI, GRBK, HPQ, KD, LIVN, LXS, MSTR, ODP, PTON, SOLB.BR, THC, TPG | Agriculture, crypto, ETFs, healthcare, Long/Short, technology, value | Greenlight discusses the speculative nature of cryptocurrencies, comparing them to collectibles with no intrinsic value. The letter highlights the emergence of memecoins like Fartcoin and Trump's official memecoin, noting the extreme valuations and speculative trading patterns in the crypto market. | CPRI CNC CNH PTON |
View |
| 2022 Q4 | Jan 17, 2023 | Greenlight Capital | 1.1% | 9.0% | AAWW, ASC, CEIX, DNMR, GRBK, RHM GR, TECK, THC, TWTR | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Fund Letters | Greenlight Capital | Tenet Healthcare | Health Care | Health Care Facilities | Bull | NYSE | asset sales, Demographics, healthcare, Hospitals, Labor Costs, Outpatient, Real Estate | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Contrarian Fund | Tenet Healthcare Corp. | Health Care | Health Care Providers & Services | Bull | NYSE | business transformation, capital allocation, debt reduction, divestitures, healthcare, Hospitals, Outpatient Surgery, return on equity, Share Buybacks | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Contrarian Fund | Tenet Healthcare Corp. | Health Care | Health Care Providers & Services | Bull | NYSE | business transformation, Healthcare services, high-margin, Hospital Divestiture, Outpatient Care, Surgery Centers | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Contrarian Fund | Tenet Healthcare Corp. | Health Care | Health Care Providers & Services | Bull | NYSE | Ambulatory surgery centers, healthcare, Healthcare services, Hospital Operator, Outpatient Surgery, Patient Growth, portfolio optimization, Strategic Transformation | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Contrarian Fund | Tenet Healthcare Corp. | Health Care | Health Care Providers & Services | Bull | NYSE | Healthcare Policy, Healthcare services, Healthcare Transformation, Hospital Operations, Medical Services, Outpatient Surgery, Patient Growth, Surgery Centers | View Pitch |
| Sep 16, 2025 | Short Thesis | Fuzzy Panda | Tenet Healthcare Corp | Health Care | Health Care Facilities (Hospitals) | Bear | NYSE | Health Care Facilities (Hospitals) | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||